225 related articles for article (PubMed ID: 28731049)
1. Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.
Perry KD; Al-Lbraheemi A; Rubin BP; Jen J; Ren H; Jang JS; Nair A; Davila J; Pambuccian S; Horvai A; Sukov W; Tazelaar HD; Folpe AL
Mod Pathol; 2017 Nov; 30(11):1589-1602. PubMed ID: 28731049
[TBL] [Abstract][Full Text] [Related]
2. Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions.
Linos K; Dermawan JK; Pulitzer M; Hameed M; Agaram NP; Agaimy A; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23198. PubMed ID: 37658696
[TBL] [Abstract][Full Text] [Related]
3. Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma.
Antonescu CR; Dickson BC; Sung YS; Zhang L; Suurmeijer AJH; Stenzinger A; Mechtersheimer G; Fletcher CDM
Am J Surg Pathol; 2020 Dec; 44(12):1677-1684. PubMed ID: 32991341
[TBL] [Abstract][Full Text] [Related]
4. Recurrent PTBP1::MAML2 fusions in composite hemangioendothelioma with neuroendocrine differentiation: A report of two cases involving neck lymph nodes.
Dermawan JK; Westra WH; Antonescu CR
Genes Chromosomes Cancer; 2022 Apr; 61(4):187-193. PubMed ID: 34862698
[TBL] [Abstract][Full Text] [Related]
5. [Retiform hemangioendothelioma: a clinicopathologic analysis of 8 cases].
Lao IW; Tang L; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):480-5. PubMed ID: 26705038
[TBL] [Abstract][Full Text] [Related]
6. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
[TBL] [Abstract][Full Text] [Related]
7. Composite Hemangioendothelioma With Neuroendocrine Marker Expression: Report of a "Paraganglioma-Like" Paravertebral Case.
Cheuk W; Shum KS; Ng WK; Chan JKC
Int J Surg Pathol; 2020 Oct; 28(7):759-763. PubMed ID: 32418470
[TBL] [Abstract][Full Text] [Related]
8. Whole Exome Sequencing Identifies Somatic Variants in an Oral Composite Hemangioendothelioma Characterized by YAP1-MAML2 Fusion.
Koutlas IG; Oetting WS; Burns GM; Gopalakrishnan R; Antonescu CR
Head Neck Pathol; 2022 Sep; 16(3):849-856. PubMed ID: 34791601
[TBL] [Abstract][Full Text] [Related]
9. Hemangioendothelioma.
Requena L; Kutzner H
Semin Diagn Pathol; 2013 Feb; 30(1):29-44. PubMed ID: 23327728
[TBL] [Abstract][Full Text] [Related]
10. Retiform hemangioendothelioma: a case series and review of the literature.
Chundriger Q; Tariq MU; Rahim S; Abdul-Ghafar J; Din NU
J Med Case Rep; 2021 Feb; 15(1):69. PubMed ID: 33593408
[TBL] [Abstract][Full Text] [Related]
11. Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue-a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study.
Pradhan D; Schoedel K; McGough RL; Ranganathan S; Rao UNM
Hum Pathol; 2018 Jan; 71():126-134. PubMed ID: 29104110
[TBL] [Abstract][Full Text] [Related]
12. Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases.
Calonje E; Fletcher CD; Wilson-Jones E; Rosai J
Am J Surg Pathol; 1994 Feb; 18(2):115-25. PubMed ID: 8291650
[TBL] [Abstract][Full Text] [Related]
13. Composite hemangioendothelioma: report of 5 cases including one with associated Maffucci syndrome.
Fukunaga M; Suzuki K; Saegusa N; Folpe AL
Am J Surg Pathol; 2007 Oct; 31(10):1567-72. PubMed ID: 17895759
[TBL] [Abstract][Full Text] [Related]
14. Primary Vascular Tumors of Bone: A Monoinstitutional Morphologic and Molecular Analysis of 427 Cases With Emphasis on Epithelioid Variants.
Righi A; Sbaraglia M; Gambarotti M; Gibertoni D; Rovira MP; Benini S; Errani C; Brenca M; Maestro R; Dei Tos AP
Am J Surg Pathol; 2020 Sep; 44(9):1192-1203. PubMed ID: 32271190
[TBL] [Abstract][Full Text] [Related]
15. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
16. Epithelioid sarcoma-like hemangioendothelioma.
Billings SD; Folpe AL; Weiss SW
Am J Surg Pathol; 2003 Jan; 27(1):48-57. PubMed ID: 12502927
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive Subset.
Shibayama T; Makise N; Motoi T; Mori T; Hiraoka N; Yonemori K; Watanabe SI; Esaki M; Morizane C; Okuma T; Kawai A; Ushiku T; Yatabe Y; Yoshida A
Am J Surg Pathol; 2021 May; 45(5):616-626. PubMed ID: 33729740
[TBL] [Abstract][Full Text] [Related]
18. [Epithelioid sarcoma-like hemangioendothelioma: a clinicopathologic and immunohistochemical study of 3 cases].
Cai JN; Peng F; Li LX; Cheng YF; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):27-31. PubMed ID: 21429355
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
[TBL] [Abstract][Full Text] [Related]
20. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
Anderson WJ; Fletcher CDM; Hornick JL
Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
